2019
DOI: 10.1007/s10571-019-00674-8
|View full text |Cite
|
Sign up to set email alerts
|

Chronic mild Hyperhomocysteinemia impairs energy metabolism, promotes DNA damage and induces a Nrf2 response to oxidative stress in rats brain

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
19
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 27 publications
(20 citation statements)
references
References 103 publications
1
19
0
Order By: Relevance
“…In our experiment, in the Met-C group was the level of Hcy increased 1.5-fold in comparison to the naïve control animals that matches the criteria for mild hHcy [ 35 , 36 ]. Dos Santos et al [ 37 ] demonstrated in their hHcy model (subcutaneous injection of DL-Hcy in the lower dose of 0.03 μmol/g of the body weight of male Wistar rats twice a day for 30 days that this dose increases rats Hcy plasma concentration, similarly described in the moderate hHcy patients. More importantly, Nuru et al [ 38 ] demonstrated that high Met diet (1.2%), low folate (0.08 mg/Kg) and low vitamin B6/B12 (0.01 mg/Kg; 10.4 μg/Kg) lead to significant neuronal damage which, interestingly precedes vascular dysfunction.…”
Section: Discussionmentioning
confidence: 91%
“…In our experiment, in the Met-C group was the level of Hcy increased 1.5-fold in comparison to the naïve control animals that matches the criteria for mild hHcy [ 35 , 36 ]. Dos Santos et al [ 37 ] demonstrated in their hHcy model (subcutaneous injection of DL-Hcy in the lower dose of 0.03 μmol/g of the body weight of male Wistar rats twice a day for 30 days that this dose increases rats Hcy plasma concentration, similarly described in the moderate hHcy patients. More importantly, Nuru et al [ 38 ] demonstrated that high Met diet (1.2%), low folate (0.08 mg/Kg) and low vitamin B6/B12 (0.01 mg/Kg; 10.4 μg/Kg) lead to significant neuronal damage which, interestingly precedes vascular dysfunction.…”
Section: Discussionmentioning
confidence: 91%
“…Recent studies on animal models of chronic HHcy showed inhibition of ETC complexes I, IV, and V in hippocampus [ 42 , 43 ], complex IV in amygdala [ 44 ], and complexes IV and V in cerebral cortex [ 42 ]. Complex II activity increased while complex IV activity decreased in amygdala of rats after chronic mild HHcy [ 45 ]. Studies showing ETC complex I inhibition, motor abnormalities, reduction of striatal dopamine level and degeneration of midbrain dopaminergic neurons in rats after infusion of Hcy into substantia nigra [ 46 ], and chronic Hcy treatment of mice [ 47 ] suggest involvement of Hcy-related dysfunction of ETC in Parkinson’s disease.…”
Section: Homocysteine and Mitochondrial Energy Metabolismmentioning
confidence: 99%
“…Similarly, acute treatment of neuron cells with high concentration of Hcy, which inhibited mitochondrial respiration, reduced the ROS level [ 54 ]. Moreover, ROS production and/or oxidative damage was unchanged in brain [ 45 ] and heart [ 36 ] of rats with chronic mild HHcy. As mentioned earlier, there are several potential mechanisms explaining how Hcy can modulate ROS production, including auto-oxidation of Hcy and altered gene expression and/or post-translational modifications of prooxidant/antioxidant proteins.…”
Section: Homocysteine and Mitochondrial Oxidative Stressmentioning
confidence: 99%
See 1 more Smart Citation
“…Homocysteine can only be derived from the catabolism of methionine . Hyperhomocysteinemia is more pronounced in diabetic patients with concurrent renal, retinal or cardiovascular complications, diabetes‐related heart disease, and stroke . Homocysteine has become an important diagnostic molecule for diabetes, and it is of great significance to develop Hcy compounds with potential clinical application value.…”
Section: Discussionmentioning
confidence: 99%